I am not sure if OSA can bring in $20M per year as a diagnosis tool given once you've been diagnosed, you buy the treatment and don't use the diagnosis tool again.....if it brings in at least $5M per year in revenue and with manufacturing cost of virtually zero, the statutory profit will be very good and will mean no CR required.
- Forums
- ASX - By Stock
- RAP
- A new Beginning...
A new Beginning..., page-2388
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1,061 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)